Bioactive by-products
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02163 |
Quinolactacin A (319917-25-4) Inquiry |
|
Quinolactactin A is a quinolone fungal metabolite that inhibits TNF production induced by LPS in murine peritoneal macrophages. |
||
BBF-02177 | ||
Rasfonin is a fungal metabolite that has been found in Talaromyces sp. 3656-A1. It is a Ras-dependent apoptosis inducer that induces apoptosis in Ras-dependent cells such as Ba/F3-V12 cells. |
||
BBF-02192 | ||
Rhodopeptin C1 is a cyclic tetrapeptide originally isolated from Rhodococcus sp. Mer-N1033. It has anti-candida and cryptococcus neoformant activities, and the MIC (μg/mL) was 1.25~2.5 and 0.63~1.25, respectively. |
||
BBF-02193 | ||
Rhodopeptin C2 is a cyclic tetrapeptide originally isolated from Rhodococcus sp. Mer-N1033. It has anti-candida and cryptococcus neoformant activities, and the MIC (μg/mL) was 1.25~2.5 and 0.63~1.25, respectively. |
||
BBF-02194 | ||
Rhodopeptin C3 is a cyclic tetrapeptide originally isolated from Rhodococcus sp. Mer-N1033. It has anti-candida and cryptococcus neoformant activities, and the MIC (μg/mL) was 1.25~2.5 and 0.63~1.25, respectively. |
||
BBF-02198 | ||
Ripromycin is produced by the strain of Streptomyces sp Tu 6239. It has moderate anti-gram-positive bacterial activity, but not anti-gram-negative bacteria or fungi. It inhibited the proliferation of HM02 and MCF cells with IC50 of 1.6 and 2.0 μg/mL, respectively. |
||
BBF-02199 | ||
Roridin C is a fungal sesquiterpene derived from Myrothecium roridum S-1135 (NRRL 3005). |
||
BBF-02200 | ||
Roridin D is originally isolated from Myrothecium roridum S-1135 (NRRL 3005). |
||
BBF-02201 |
Roridine H (29953-50-2) Inquiry |
|
Roridin E is originally isolated from Myrothecium roridum S-1135 (NRRL 3005). |
||
BBF-02202 | ||
Roridin J is originally isolated from Myrothecium roridum S-1135 (NRRL 3005) and it has anti-leukemia effect in mice. |
||
BBF-02203 |
Roridin L2 (85124-22-7) Inquiry |
|
Roridin L2 is originally isolated from M. roridum var. and it has antibacterial and antitumor effects. |
||
BBF-02333 |
Pacidamycin 1 (121264-05-9) Inquiry |
|
It is produced by the strain of Str. coeruleorubidus AB 1183F-64. It has inhibitory effect on Pseudomonas aeruginosa. It also has effect on a few strains of bacteria such as suppurative staphylococcus and Escherichia coli. Serum can reduce its antibacterial activity, pH also affects its antibacterial activity. pH 6.5, The antibacterial activity of Pacidamycin 1 can be enhanced twice. In vivo test of mice infected with pseudomonas aeruginosa (100 mg/kg·d) showed no protective effect. |
||
BBF-02334 |
Pacidamycin 2 (121264-06-0) Inquiry |
|
It is produced by the strain of Str. coeruleorubidus AB 1183F-64. It has inhibitory effect on Pseudomonas aeruginosa. It also has effect on a few strains of bacteria such as suppurative staphylococcus and Escherichia coli. Serum can reduce its antibacterial activity, pH also affects its antibacterial activity. |
||
BBF-02335 |
Pacidamycin 3 (121280-49-7) Inquiry |
|
It is produced by the strain of Str. coeruleorubidus AB 1183F-64. It has inhibitory effect on Pseudomonas aeruginosa. It also has effect on a few strains of bacteria such as suppurative staphylococcus and Escherichia coli. Serum can reduce its antibacterial activity, pH also affects its antibacterial activity. |
||
BBF-02336 |
Pacidamycin 5 (122855-43-0) Inquiry |
|
It is produced by the strain of Str. coeruleorubidus AB 1183F-64. It has inhibitory effect on Pseudomonas aeruginosa. It also has effect on a few strains of bacteria such as suppurative staphylococcus and Escherichia coli. Serum can reduce its antibacterial activity, pH also affects its antibacterial activity. |
||
BBF-02362 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |
||
BBF-02363 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |
||
BBF-02364 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. |
||
BBF-02365 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |
||
BBF-02366 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |